REFERENCES
- Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81(4A):7B–12B.
- Chen J, Raymond K. Beta-glucans in the treatment of diabetes and associated cardiovascular risks. Vasc Health Risk Manag. 2008;4:1265–1272.
- Cugnet-Anceau C, Nazare JA, Biorklund M, Le Coquil E, Sassolas A, Sothier M, Holm J, et al. A controlled study of consumption of beta-glucan-enriched soups for 2 months by type 2 diabetic free-living subjects. Br J Nutr. 2010;103:422–428.
- Dedeepiya V, Sivaraman G, Venkatesh A, Preethy S, Abraham S. Potential effects of nichi glucan as a food supplement for diabetes mellitus and hyperlipidemia; preliminary findings from the study on three patients from India. Case Rep Med. 2012;2012:895370.
- Filippatos TD, Elisaf MS. High density lipoprotein and cardiovascular diseases. World J Cardiol. 2013;5:210–214.
- Ikegami, et al. Aureobasidium pullulans (Black Yeast)-derived Beta Glucan-its multi-varied functions and potential applications. Food Industry. 2007;50 (Article in Japanese).
- Ikewaki N, Fujii N, Onaka T, Ikewaki S, Inoko H. Immunological actions of Sophy beta-glucan (beta-1,3-1,6 glucan), currently available commercially as a health food supplement. Microbiol Immunol. 2007;51:861–873.
- Japanese Ministry of Health and Welfare Document. Study on the safety evaluation of existing Natural additives. 15th March 1996 Ref. No 214.
- Kostapanos MS, Milionis HJ, Elisaf MS. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia. Am J Cardiovasc Drugs. 2010;10:11–28.
- Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al; American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123:2292–2333.
- Miyamoto M, et al. Impact on NK cell activity by gastronomy or nasal tube feeding of β-glucan black yeast in the elderly. In 27th Japan Society of Parenteral and Enteral Nutrition. 2012 (Abstract in Japanese).
- Ren J, Grundy SM, Liu J, Wang W, Wang M, Sun J, et al. Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese: the results of a 15-Year Chinese Multi-Provincial Cohort Study (CMCS). Atherosclerosis. 2010;211:327–332.
- Saito Y, Yamada N, Shirai K, Sasaki J, Ebihara Y, Yanase T, Fox JC. Effect of rosuvastatin 5–20 mg on triglycerides and other lipid parameters in Japanese patients with hypertriglyceridemia. Atherosclerosis. 2007;194:505–511.
- Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation. 2007;115:450–458.
- Sparks JD, Sparks CE, Adeli K. Selective hepatic insulin resistance, very-low-density lipoprotein hyper-secretion and hyper-triglyceridemia. Arterioscler Thromb Vasc Biol. 2012;32:2104–12.
- Tiwari U, Cummins E. Meta-analysis of the effect of β-glucan intake on blood cholesterol and glucose levels. Nutrition. 2011;27:1008–1016.
- Vetvicka V, Vetvickova J. Effects of yeast-derived beta-glucans on blood cholesterol and macrophage functionality. J Immunotoxicol. 2009;6:30–35.